公开(公告)号：WO2022132997A1

公开(公告)日：2022-06-23

申请号：PCT/US2021/063660

申请日：2021-12-16

Applicant: ABBVIE INC.

Inventor： DEGOEY, David A. ,  DEANDA, JR., Felix ,  DOMBROWSKI, Amanda W. ,  DUBOVYK, Igor ,  GRESZLER, Stephen N. ,  KHRAKOVSKY, Dimitri ,  LEE, Chih-Hung ,  NEWTON, James N. ,  NOEY, Elizabeth L. ,  OKANO, Akinori ,  SIPPY, Kevin B. ,  SOUERS, Andrew J. ,  WANG, Longcheng ,  WILSON, Noel S. ,  ZABLOCKI, Jeffery A.

IPC: A61K31/4162 ,  A61K31/437 ,  C07D471/04 ,  A61P35/00 ,  C07D487/04 ,  C07D519/00

Abstract: The present invention provides for compounds of formula (I); wherein A, R1, R2, R4, W, m, and n have any of the values defined herein, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of CLL and/or SLL.